학술논문

A phase I/II trial of antibody directed enzyme prodrug therapy (ADEPT) with MFECP1 and ZD2767P
Document Type
Journal
Source
BRITISH JOURNAL OF CANCER; JUL 2004, 91 pS8-pS8, 1p. Supplement: 1
Subject
Language
English
ISSN
00070920